ChemoCentryx, Inc. Insider Trading for March 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ChemoCentryx, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ChemoCentryx, Inc. for March 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 31 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | A | 46.52 | 16,510 | 768,045 | 16,510 | |
Mar 31 2020 | CCXI | ChemoCentryx, Inc. | Jain Rita | Director | Option Exercise | M | 0.00 | 5,251 | 0 | 10,502 | |
Mar 31 2020 | CCXI | ChemoCentryx, Inc. | Jain Rita | Director | Buy | M | 0.00 | 5,251 | 0 | 12,975 | 7.7 K to 13 K (+67.98 %) |
Mar 25 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 38.21 | 860 | 32,863 | 49,600 | 50.5 K to 49.6 K (-1.70 %) |
Mar 25 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 37.40 | 13,959 | 522,008 | 50,460 | 64.4 K to 50.5 K (-21.67 %) |
Mar 25 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 36.72 | 9,181 | 337,100 | 64,419 | 73.6 K to 64.4 K (-12.47 %) |
Mar 25 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 35.32 | 2,801 | 98,932 | 73,600 | 76.4 K to 73.6 K (-3.67 %) |
Mar 25 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 34.43 | 3,199 | 110,147 | 76,401 | 79.6 K to 76.4 K (-4.02 %) |
Mar 05 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | A | 46.59 | 71,500 | 3,331,185 | 71,500 | |
Mar 05 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | A | 0.00 | 103,700 | 0 | 103,700 | |
Mar 05 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 14.31 | 40,844 | 584,478 | 246,038 | |
Mar 05 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 50.35 | 40,844 | 2,056,691 | 2,268,557 | 2.3 M to 2.3 M (-1.77 %) |
Mar 05 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 14.31 | 40,844 | 584,478 | 2,309,401 | 2.3 M to 2.3 M (+1.80 %) |
Mar 05 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | A | 46.59 | 21,400 | 997,026 | 21,400 | |
Mar 05 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | A | 0.00 | 31,000 | 0 | 31,000 | |
Mar 05 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | A | 46.59 | 16,100 | 750,099 | 16,100 | |
Mar 05 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | A | 0.00 | 23,300 | 0 | 23,300 |